Jerusalem Pharmaceuticals Co. Ltd.

JPH

PS2016112695

Pharmaceuticals

End-of-day quote Palestine Exchange Other stock markets 06:00:00 2024-04-24 pm EDT			5-day change	1st Jan Change
3.81 ^USD	0.00%		-0.52%	+0.26%

2023	Jerusalem Pharmaceuticals Co. Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
2023	Jerusalem Pharmaceuticals Co. Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI

Jerusalem Pharmaceuticals Co. Ltd. Announces Audited Consolidated Earnings Results for the Year Ended December 31, 2018

March 30, 2019

Jerusalem Pharmaceuticals Co. Ltd. announced audited consolidated earnings results for the year ended December 31, 2018. For the year, the company reported sales of USD 34,878,975 as compared to USD 35,154,346 a year ago. Net Income after tax was USD 6,002,857 as compared to USD 6,163,670 a year ago. Basic and diluted loss per share were USD 0.340 as compared to USD 0.341 a year ago.

Latest news about Jerusalem Pharmaceuticals Co. Ltd.

Jerusalem Pharmaceuticals Co. Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Dec. 06	CI
Jerusalem Pharmaceuticals Co. Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-09	CI
Jerusalem Pharmaceuticals Co. Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-13	CI
Jerusalem Pharmaceuticals Co. Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-31	CI
Jerusalem Pharmaceuticals Co. Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-09	CI
Jerusalem Pharmaceuticals Co. Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-14	CI
Jerusalem Pharmaceuticals Co. Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-14	CI
Jerusalem Pharmaceuticals Co. Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-30	CI
Jerusalem Pharmaceuticals Co. Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-10-31	CI
Jerusalem Pharmaceuticals Co. Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-15	CI
Jerusalem Pharmaceuticals Co. Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020	21-05-09	CI
Jerusalem Pharmaceuticals Co. Ltd. Announces Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2019	19-04-29	CI
Jerusalem Pharmaceuticals Co. Ltd. Announces Audited Consolidated Earnings Results for the Year Ended December 31, 2018	19-03-30	CI
Jerusalem Pharmaceuticals Co. Ltd. Reports Consolidated Unaudited Earnings Results for the Year Ended December 31, 2018	19-02-16	CI
Jerusalem Pharmaceuticals Co. Ltd. Reports Unaudited Earnings Results for the Nine Months Ended September 30, 2018	18-10-31	CI
Jerusalem Pharmaceuticals Co. Ltd. Reports Consolidated Earnings Results for the First Half of 2018	18-08-30	CI
Jerusalem Pharmaceuticals Co. Ltd. Announces Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2018	18-04-28	CI
Jerusalem Pharmaceuticals Co. Ltd. Announces Audited Consolidated Earnings Results for the Year Ended December 31, 2017	18-03-30	CI
Jerusalem Pharmaceuticals Co. Ltd. Announces Unaudited Earnings Results for the Full Year Ended December 31, 2017	18-02-14	CI
Jerusalem Pharmaceuticals Co. Ltd. Reports Unaudited Consolidated Earnings Results for the Nine Months Ended September 30, 2014	14-10-28	CI
Jerusalem Pharmaceuticals Company Reports Audited Consolidated Earnings Results for the Year 2013	14-03-30	CI
Jerusalem Pharmaceuticals Co. Announces Unaudited Consolidated Preliminary Financial Results for Year Ended December 31, 2013	14-02-12	CI

Chart Jerusalem Pharmaceuticals Co. Ltd.

Duration

Period

Chart Jerusalem Pharmaceuticals Co. Ltd.

More charts

Company Profile

Jerusalem Pharmaceuticals Co Ltd (Al-Quds) is a Palestine-based public shareholding company engaged in the manufacture and trade of pharmaceutical, veterinary, detergent, and cosmetics products. Its product range spans the whole spectrum of ethical pharmaceuticals, as well as over the counter preparations and nutritional supplements. Its Products are presented in different dosage forms such as tablets, capsules, ampoules, granules and powders for suspensions, suspensions, syrups, lotions, powders, suppositories, ovules, creams, ointments, gels, emulgels, ear, eye and nose drops, solutions, mouth rinse and gargles. The Company also produces veterinary products including vials, powders, oral liquids and fodder additives such as multivitamins and multi-minerals. It also manufactures detergents and cosmetics under license from French companies. The Company operates three production facilities include Factory for General Production, Penicillin Factory and Cephalosporin Factory.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
JERUSALEM PHARMACEUTICALS CO. LTD.	+0.26%	68.58M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+19.62%	43.78B
OTSUKA HOLDINGS CO., LTD.	+20.44%	21.89B
SANDOZ GROUP AG	+10.86%	14.45B
CIPLA LIMITED	+13.07%	13.63B
ZYDUS LIFESCIENCES LIMITED	+37.46%	11.49B
ONO PHARMACEUTICAL CO., LTD.	-8.59%	6.85B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+8.46%	5.06B